Company / Interest Expense
Dianthus Therapeutics, Inc. /DE/ Interest Expense History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$163.0K
FY2016
5-year range
-
FY2016-FY2016
Trend
-
vs FY2015
Sector context
#38 of 44
Health Care
What the data says
Dianthus Therapeutics, Inc. /DE/'s interest expense of $163,000 is lower than 86% of companies in the Health Care sector (FY2016).
Based on SEC 10-K filings.
$163,000 in FY2016.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $163.0K Sector average $291.0M
▼
-99.9% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $163.0K | - |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026